SF 2154 Iowa Senate · 2025-2026 Regular Session

A bill for an act relating to the distribution of gene-based vaccines and providing penalties.

This bill requires manufacturers of mRNA and DNA-based vaccines to conduct safety studies on transmissibility, DNA contamination, and shedding before distributing them in Iowa. Distributors who provide vaccines posing unreasonable public health risks (as defined by the FDA) face $1,000 fines per violation and potential licensing penalties. It also removes liability immunity for manufacturers if a vaccine’s design defect causes injury or death. The Department of Inspections must create enforcement rules under this law. The bill directly affects vaccine manufacturers, distributors, and healthcare providers handling these vaccines within Iowa.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 29, 2026 Last action Feb 4, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
1
Committee
1
Feb 4, 2026
Upper · Passed
Subcommittee: Sweeney, Petersen, and Webster.
upper
Jan 29, 2026
Introduced
Introduced, referred to Health and Human Services.
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Doug Campbell
Doug Campbell
RRepublican
IA
30